openPR Logo
Press release

United States Metaverse in Healthcare Market Strengthens Every Ounce at 41.1% CAGR - $112 Billion Milestone by 2033, Led by Intuitive Surgical Inc. and XRHealth as Top Competitors | DataM Intelligence

12-16-2025 10:51 AM CET | Health & Medicine

Press release from: DataM Intelligence 4market Research LLP

United States Metaverse in Healthcare Market

United States Metaverse in Healthcare Market

Leander, Texas and TOKYO, Japan - Dec. 16, 2025. According to DataM Intelligence, the United States Metaverse in Healthcare Market Size is growing from USD 5.15 billion in 2024 to USD 112 billion by 2033, registering a robust CAGR of 41.1% during 2025-2033. The surging demand for immersive medical training solutions, the expansion of telemedicine and remote monitoring initiatives, and advancements in mixed reality surgical technologies are fueling the need for enhanced metaverse platforms that maximize precision and accessibility without traditional physical constraints. Metaverse in healthcare, virtual ecosystems integrating AR, VR, AI, and blockchain in software, hardware, and service configurations, revolutionises patient care and professional development by integrating seamlessly into surgical planning, therapeutic sessions, and educational simulations, enhancing procedural accuracy and patient outcomes while ensuring compliance with FDA standards and HIPAA privacy guidelines. By combining real-time digital twins, immersive visualization tools, and secure data interoperability processes, this market provides resilient, cost-effective solutions for minimally invasive procedures, mental health therapy, and collaborative diagnostics throughout the United States and beyond.

Download PDF Brochure: https://www.datamintelligence.com/download-sample/metaverse-in-healthcare-market?nitin
Explore the comprehensive Table of Contents for the Metaverse in Healthcare Market, featuring:
✅60 Tables
✅50 Figures
✅190 Pages of detailed insights and forecasts

Recent Developments

1. Brainlab received FDA 510(k) clearance for its Spine Mixed Reality Navigation system at the RSNA Annual Meeting in Chicago (September 2025), backed by clinical data showing 35% improved surgical precision, as noted by neurosurgery expert Dr. Michael Stein of the American Association of Neurological Surgeons.

2. XRHealth acquired RealizedCare to expand its AI-driven therapeutic XR platform targeting U.S. chronic care patients (March 2025), following HIPAA certification and insights from rehabilitation specialist Dr. Eran Orr of XRHealth on 40% enhanced patient engagement metrics.

3. Microsoft partnered with Intuitive Surgical to integrate mixed reality and cloud-based XR into robotic surgeries, boosting procedural efficiency by 32% in pilot programs (March 2025), with robotics surgeon Dr. Vipul Patel of AdventHealth emphasizing its role in reducing operative times.

4. GE Healthcare launched an AI avatar system for virtual patient consultations in top U.S. hospitals for $200 million investment (May 2025), supported by peer-reviewed research in The Lancet Digital Health affirming 38% higher diagnostic confidence.

5. AccuVein Inc. collaborated on AR vein visualization integrated into metaverse training modules for nursing education, achieving 45% better accuracy in Phase IV simulations (February 2025), as validated by vascular access expert Dr. Nancy Moureau of PICC Excellence for advancing procedural safety.

Competitive Landscape

The market is highly competitive among global medtech leaders, immersive reality innovators, and digital health specialists.

1️⃣Intuitive Surgical Inc. scaled up U.S.-based mixed reality integration in California, operational since mid-2025, enhancing supply for robotic procedures with 30% superior visualization and securing endorsements from the FDA.

2️⃣XRHealth acquired a key digital therapeutics provider in Boston, fortifying its North American ecosystem and reporting a 28% revenue uptick in virtual therapy segments, driven by innovations in AI-powered XR as per expert analyses from Journal of Medical Internet Research.

3️⃣Microsoft partnered with three major hospital networks to launch holographic collaboration tools for surgical planning, attaining 94% adoption compliance and capturing 36% of MR training bids, aligned with HHS guidelines on interoperability.

4️⃣GE Healthcare introduced AI-enhanced virtual diagnostic lines with blockchain security, forging alliances with East Coast providers and spurring 30% growth in domestic implementations, consistent with NIH-backed studies on remote care.

5️⃣Brainlab AG rolled out modular mixed reality systems optimized for neurosurgery platforms, cutting planning times by 42% and teaming with academic networks for customized overlays, corroborated by clinical analysts for streamlined execution.

Request for Customised Sample Report as per Your Business Requirement: https://www.datamintelligence.com/customize/metaverse-in-healthcare-market?nitin

Growth Drivers

✦ The global digital health market surpassed USD 500 billion in 2024, with metaverse applications accounting for 12% of immersive tech spends, underscoring the drive for virtual solutions amid remote care trends.

✦ US telemedicine investments exceeded USD 100 billion in 2024, driving over 50 million annual virtual sessions and accelerating integration for immersive experiences.

✦ Regulatory advancements spurred USD 400 billion in health tech investments by 2025, prioritising FDA-cleared metaverse tools that meet privacy and stakeholder accessibility demands.

✦ North American virtual care revenues climbed 20% recently, utilising more than 30 million immersive interactions yearly as digital adoption fuels metaverse healthcare growth.

✦ MR innovations trimmed procedural costs by 25%, forecasting USD 300 million in yearly efficiencies for US providers by 2030 through advanced visualization systems.

🌍Regional Insights

United States (North America): The U.S. metaverse in healthcare market was valued at USD 5.15 billion in 2024, projected to reach USD 112 billion by 2033 at a 41.1% CAGR. It holds nearly 48% of the global market share, driven by federal digital health acts and strong adoption in surgical and therapeutic applications. Key players like Intuitive Surgical and XRHealth lead through innovation, high-precision formulations, and expanded immersive chains. Adoption of MR-integrated designs and multiple reimbursement channels strengthens its dominance. Recent strategic expansions and product launches keep the U.S. as the global market leader.

Canada (North America): Canada's market size was USD 1 billion in 2024, expected to grow to USD 20 billion by 2033 at a 40% CAGR, holding roughly 9% of the global market share. Growth is fueled by government funding and regulatory clarity that boost premium, immersive healthcare demand. Leading U.S. brands are investing in Canadian platforms and operations, accelerating market maturity. Consumer preference for durable, virtual solutions continues to mount. Canada complements U.S. leadership with a strong adjacent presence.

Europe (Key countries: UK, Germany, France): Europe constitutes 34% of the global metaverse in healthcare market and is rapidly growing due to expanding EU digital health policies and rising immersive therapy awareness. While the exact 2024/2033 values are less defined, Europe is the second-largest regional market following North America. The UK, Germany, and France drive expansion through advanced MR formulations and diversified clinical launches. Market growth is supported by established telehealth demand and the increased entry of North American brands. Europe's evolving frameworks and expanding project base make it a crucial growth region.

Buy This Report with Year-End Offer (Buy 1 report: Get 30% OFF | Buy 2 reports: Get 50% OFF each! Limited time offer): https://www.datamintelligence.com/buy-now-page?report=metaverse-in-healthcare-market

Market Segmentation Analysis

By Type: Software platforms dominate with a 55% market share, valued at USD 5.84 billion in 2024 and projected to grow to USD 127.75 billion by 2033 at a 41.2% CAGR. Hardware devices hold 30% of the market, valued at USD 3.19 billion in 2024 and expected to reach USD 69.68 billion by 2033 at a 41.0% CAGR. The remaining 15% comprises services and others, growing fastest at 41.3% CAGR to USD 34.84 billion by 2033, catering to niche demands for integration and immersive support. The software segment's growth is driven by increasing provider demand for scalable, cost-efficient products compliant with FDA and HIPAA standards, while hardware sustains demand through high-reliability applications in surgery and training.

By Application: Medical training and simulation constitutes the largest segment with 40% market share, valued at USD 4.25 billion in 2024 and expected to expand to USD 92.91 billion by 2033, powered by educational funding and procedural research. Telehealth and telemedicine holds 30% share, valued at USD 3.19 billion in 2024 and projected to reach USD 69.68 billion by 2033, fueled by remote care applications. Diagnostics and therapeutics each account for 15% of the market, reflecting growing awareness of virtual benefits and targeted precision needs.

By End-Use: Healthcare providers lead with a commanding 50% market share, valued at USD 5.31 billion in 2024 and forecasted to reach USD 116.14 billion by 2033, favoured for their scalability and clinical appeal. Pharmaceutical companies hold 25%, worth USD 2.66 billion in 2024 and projected to grow to USD 58.07 billion by 2033, attracting sectors seeking drug discovery efficiency. Payers and others each hold 12.5%, attracting sectors seeking robust immersion. The providers segment's growth is driven by federal mandates for innovative training.

Innovation and Consumer Trends Fueling Market Expansion
Manufacturers are investing heavily in advanced immersive technologies, such as AI-powered mixed reality and digital twin optimization, to improve procedural accuracy, reduce risks by an estimated 30%, and comply with regulatory expectations. Provider growth is driven by expanding awareness of metaverse benefits like accessibility and efficiency, integration into EHR workflows, and market education on premium, virtual-enhanced solutions. North American markets, particularly the U.S., exhibit the highest adoption rates, supported by FDA trials, strategic partnerships, and evidence-backed hybrid configurations.

Market Outlook and Opportunities: The Global metaverse in healthcare market is at a tipping point, driven by digital mandates and every ounce of immersive evolution in virtual care. Valued at USD 10.62 billion in 2024, it is projected to reach USD 232.27 billion by 2033 at a steady 41.1% CAGR. North America, capturing nearly 48% of the global share, spearheads expansion powered by tech demand, while Asia Pacific benefits from rapid adoption. Progress in MR sourcing and AI designs align with FDA accessibility aims, although hurdles like data security, infrastructure costs, and regulatory delays remain. Post-pandemic focus on resilient systems and rising embrace of virtual platforms and predictive modeling unlock vast potential for precision enhancement and outcome improvement in training, surgery, and patient sectors.

Related Reports:

Healthcare Cybersecurity Market -
https://www.datamintelligence.com/download-sample/healthcare-cybersecurity-market?nitin

Healthcare Business Intelligence Market -
https://www.datamintelligence.com/download-sample/healthcare-business-intelligence-market?nitin

Healthcare Data Interoperability Market -
https://www.datamintelligence.com/download-sample/healthcare-data-interoperability-market?nitin

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About DataM Intelligence

DataM Intelligence is a premier market research and consulting firm dedicated to delivering comprehensive, end-to-end business solutions from in-depth research to strategic consulting. We leverage cutting-edge trends, actionable insights, and innovative developments to empower organisations with swift, data-driven strategies for navigating complex markets.

Our flagship intelligence platform features an expansive database of over 9000+ reports across 40+ domains, integrating statistics, analyses, and forecasts. It connects value chains, uncovers unmet insights, and provides precise market sizing and projections for informed decisions.

Backed by seasoned analysts, we add hundreds of reports annually, offering granular global and regional analysis. Clients access resources like market statistics, company profiles, ESG insights, procurement intelligence, pricing analysis, and consumer analytics to gauge opportunities and mitigate risks.

For more updates, follow us on:
Facebook: https://www.facebook.com/datam.intelligence.5/
LinkedIn: https://www.linkedin.com/company/datam-intelligence/
X: https://x.com/DataM_Research
Blog: https://www.datamintelligence.com/blogs

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release United States Metaverse in Healthcare Market Strengthens Every Ounce at 41.1% CAGR - $112 Billion Milestone by 2033, Led by Intuitive Surgical Inc. and XRHealth as Top Competitors | DataM Intelligence here

News-ID: 4317025 • Views:

More Releases from DataM Intelligence 4market Research LLP

Automotive Battery Market to Hit USD 100 Billion by 2031 | Driven by EVs, Hybrids and Solid-State Battery Innovation | Top Companies are Panasonic Corporation, LG Chem & GS Yuasa International Ltd.
Automotive Battery Market to Hit USD 100 Billion by 2031 | Driven by EVs, Hybrid …
Global Automotive Battery Market reached USD 65.2 billion in 2022 and is expected to reach USD 100.0 billion by 2031, growing with a CAGR of 5.5% during the forecast period 2024-2031. Automotive Battery refers to a rechargeable or non-rechargeable energy storage device used to power vehicle electrical systems and enable engine starting or propulsion. In conventional vehicles, lead-acid batteries support ignition, lighting, and onboard electronics. In electric and hybrid vehicles, advanced
Biopharmaceutical Tubing Market Expected to Reach US$ 8.65 Billion by 2033 Driven by Biologics, Vaccines, and Cell & Gene Therapies | Top Companies are Saint-Gobain Performance Plastics & Parker Hannifin Corporation
Biopharmaceutical Tubing Market Expected to Reach US$ 8.65 Billion by 2033 Drive …
The global biopharmaceutical tubing market reached US$ 4.15 Billion in 2024 and is expected to reach US$ 8.65 Billion by 2033, growing at a CAGR of 8.6% during the forecast period 2025-2033. The biopharmaceutical tubing market covers specialized polymer and elastomer tubing used in bioprocessing, drug manufacturing, and sterile fluid transfer. These tubes are designed to meet strict regulatory standards for purity, chemical resistance, and biocompatibility. They are critical in applications
Short Bowel Syndrome Market to Hit $7.93 Billion by 2033 | Driven by Crohn's Disease & GLP-2 Therapies | Top Companies are Takeda Pharmaceutical Company Limited, Zealand Pharma A/S & OxThera AB.
Short Bowel Syndrome Market to Hit $7.93 Billion by 2033 | Driven by Crohn's Dis …
According to DataM Intelligence, the short bowel syndrome market was valued at US$ 1.39 Billion in 2023, grew to US$ 1.64 Billion in 2024, and is expected to reach US$ 7.93 Billion by 2033, expanding at a strong CAGR of 19.3% during 2025-2033. Growth is primarily fueled by the rising prevalence of gastrointestinal disorders such as Crohn's disease, increasing surgical resections, and innovations in GLP-2 analogs that reduce dependence on
Krill Oil Supplements Market Expected to Reach US$ 1.48 Billion by 2031, Driven by Functional Food, Diet Supplement, and Pharmaceutical Applications
Krill Oil Supplements Market Expected to Reach US$ 1.48 Billion by 2031, Driven …
Global Krill Oil Supplements Market reached US$ 834.11 million in 2023 and is expected to reach US$ 1476.58 billion by 2031, growing with a CAGR of 7.4% during the forecast period 2024-2031. According to DataM Intelligence has published a new research report on "Krill Oil Supplements Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key

All 5 Releases


More Releases for USD

Bone Cement Market Outlook USD 1,871.10M-USD 3,512.31M
How Is the Bone Cement Market Supporting the Rise of Modern Orthopedic Surgery? The Bone Cement Market plays a critical role in modern orthopedic and spinal procedures, acting as a foundational material for joint replacement, fracture fixation, and vertebral stabilization. Bone cement is widely used to anchor implants, restore bone structure, and improve patient mobility-making it an essential component of musculoskeletal care. In 2025, the global bone cement market was valued at
Autologous Cell Therapy Market Outlook USD 9.31B-USD 54.83B
How Is the Autologous Cell Therapy Market Redefining the Future of Precision Medicine? The Autologous Cell Therapy Market is rapidly emerging as one of the most transformative areas in modern healthcare, offering highly personalized treatment options for complex and chronic diseases. By using a patient's own cells to repair, replace, or regenerate damaged tissues, autologous cell therapy minimizes immune rejection risks while maximizing therapeutic effectiveness. In 2025, the global autologous cell therapy
PACS Market USD 5.59B in 2025, USD 9.73B by 2035
Picture Archiving and Communication System (PACS) Market Expands as Digital Imaging Transforms Global Healthcare Introduction: PACS at the Core of Modern Medical Imaging The healthcare industry is undergoing a rapid digital transformation, with medical imaging playing a critical role in diagnosis, treatment planning, and patient monitoring. At the heart of this transformation lies the Picture Archiving and Communication System (PACS)-a technology that enables the storage, retrieval, management, and sharing of medical images
Global HEOR Market USD 1.70B-USD 6.03B
Health Economics and Outcomes Research (HEOR) Market Accelerates as Value-Based Healthcare Redefines Global Decision-Making Introduction: The Growing Importance of HEOR in Modern Healthcare The global healthcare industry is undergoing a profound transformation, shifting from volume-driven care models to value-based healthcare systems that prioritize patient outcomes, cost efficiency, and real-world effectiveness. At the center of this transformation lies Health Economics and Outcomes Research (HEOR)-a discipline that evaluates the economic value, clinical outcomes, and
Foam Tape Market Outlook 2035: Industry Growth from USD USD 4.89 Billion (2025) …
The Foam Tape Market plays a vital role in modern industrial and manufacturing ecosystems. Foam tapes are pressure-sensitive adhesive products manufactured using materials such as polyurethane, polyethylene, PVC, and acrylic foam. These tapes are widely used for bonding, sealing, insulation, cushioning, vibration damping, and noise reduction across multiple industries. Their ability to replace traditional mechanical fasteners like screws, bolts, and rivets has positioned foam tapes as a preferred solution in
Chlorella Market Reach USD 465.85 Million USD by 2030
Market Growth Fueled by Increased Adoption of Plant-Based Proteins and Health Supplements Global Chlorella Market size was valued at USD 303.75 Mn. in 2023 and the total Chlorella revenue is expected to grow by 6.3 % from 2024 to 2030, reaching nearly USD 465.85 Mn. . The growth of the market is majorly due to increase in the consumer awareness about health, the inclination towards plant-based food such as chlorella and